accountcuts of 1 percent to 2 percent on medicines mandated by European governments have been commonplace, Phil Johnson, Eli Lilly & Co.s vice president of investor relations, said last month. Whats new is that more countries are demanding deeper price...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pharma Profits Squeezed as Europe Cuts Costs
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account